Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma (Q65334516)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma |
clinical trial |
Statements
A Phase 3 Randomized Double-blind, Controlled Study of ICT-107 With Maintenance Temozolomide (TMZ) in Newly Diagnosed Glioblastoma Following Resection and Concomitant TMZ Chemoradiotherapy (English)
0 references
December 2015
0 references
December 2019
0 references
414
0 references
18 year
0 references